Highlights and Quick Summary
- Annual Average Days of Payables for 2021 was 511.5 (a -55.4% decrease from previous year)
- Annual Average Days of Payables for 2020 was 1146.87 (a -83.2% decrease from previous year)
- Annual Average Days of Payables for 2019 was 6825.28 (a -31.78% decrease from previous year)
- Twelve month Average Days of Payables ending March 31, 2022 was 0.0 (a -100.0% decrease compared to previous quarter)
- Twelve month trailing Average Days of Payables decreased by -100.0% year-over-year
Trailing Average Days of Payables for the last four month:
31 Mar '22 | 31 Dec '21 | 30 Sep '21 | 30 Jun '21 |
---|---|---|---|
0.0 | 511.5 | 1444.25 | 1225.25 |
Visit stockrow.com/ALNA
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Average Days of Payables of Allena Pharmaceuticals, Inc.
Most recent Average Days of Payablesof ALNA including historical data for past 10 years.Interactive Chart of Average Days of Payables of Allena Pharmaceuticals, Inc.
Allena Pharmaceuticals, Inc. Average Days of Payables for the past 10 Years (both Annual and Quarterly)
Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
---|---|---|---|---|---|
2021 | – | – | – | – | 511.5 |
2020 | – | – | – | – | 1146.87 |
2019 | – | – | – | – | 6825.28 |
2018 | – | – | – | – | 10004.74 |
2017 | – | – | – | – | 8620.0 |
2016 | – | – | – | – | 11616.52 |
2015 | – | – | – | – | 0.0 |
Business Profile of Allena Pharmaceuticals, Inc.
Sector: Healthcare
Industry: Biotechnology
Allena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States. Its lead product candidate is ALLN-346, a novel and urate degrading enzyme for patients with hyperuricemia and gout in the setting of advanced chronic kidney disease. The company was incorporated in 2011 and is headquartered in Newton, Massachusetts.